{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:38:22Z","timestamp":1772120302527,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016304","name":"Medtronic Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.amjcard.2023.08.076","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T13:38:11Z","timestamp":1694180291000},"page":"108-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Aspirin Versus Warfarin after Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Follow-Up"],"prefix":"10.1016","volume":"206","author":[{"given":"Ilan","family":"Merdler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Case","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhdeep","family":"Bhogal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan K.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsik","family":"Ben-Dor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lowell F.","family":"Satler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaby","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4063-9226","authenticated-orcid":false,"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.08.076_bib0001","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0002","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.jacc.2018.08.1033","article-title":"Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis","volume":"72","author":"Waksman","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009608","article-title":"Hemodynamics and subclinical leaflet thrombosis in low-risk patients undergoing transcatheter aortic valve replacement","volume":"12","author":"Khan","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0004","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jcin.2016.11.027","article-title":"Outcomes of warfarin therapy for bioprosthetic valve thrombosis of surgically implanted valves: A prospective study","volume":"10","author":"Egbe","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0005","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2019.12.037","article-title":"Long-term outcomes of anticoagulation for bioprosthetic valve thrombosis","volume":"75","author":"Petrescu","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0006","doi-asserted-by":"crossref","first-page":"e1748","DOI":"10.4244\/EIJ-D-17-01062","article-title":"Bioprosthetic aortic valve leaflet thrombosis detected by multidetector computed tomography is associated with adverse cerebrovascular events: a meta-analysis of observational studies","volume":"13","author":"Rashid","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0007","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0008","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0009","first-page":"e521","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of Rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009983","article-title":"Randomized trial of aspirin versus warfarin after transcatheter aortic valve replacement in low-risk patients","volume":"14","author":"Rogers","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0012","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/ejcts\/ezs533","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)","volume":"42","author":"Kappetein","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0013","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012655","article-title":"Transcatheter aortic valve replacement and impact of subclinical leaflet thrombosis in low-risk patients: LRT trial 4-year outcomes","volume":"16","author":"Waksman","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.carrev.2022.03.006","article-title":"Durability of surgical and transcatheter aortic bioprostheses: a review of the literature","volume":"42","author":"Casenghi","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2022.05.011","article-title":"Transcatheter aortic bioprosthesis durability: a single-center experience","volume":"43","author":"Moroni","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/17434440.2019.1557045","article-title":"The Evolut R and Evolut PRO transcatheter aortic valve systems","volume":"16","author":"Choudhury","year":"2019","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0018","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jacc.2021.11.062","article-title":"2-year outcomes after transcatheter versus surgical aortic valve replacement in low-risk patients","volume":"79","author":"Forrest","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0019","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2019.06.076","article-title":"Transcatheter versus surgical aortic valve replacement in low-risk patients","volume":"74","author":"Kolte","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0020","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0021","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0022","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2015.11.008","article-title":"Rationale and design of POPULAR-TAVI: Antiplatelet therapy for patients undergoing transcatheter aortic valve implantation","volume":"173","author":"Nijenhuis","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2018.03.008","article-title":"Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial","volume":"200","author":"Collet","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2023.08.076_bib0024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2018.06.006","article-title":"Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: insights from the STS\/ACC TVT registry","volume":"204","author":"Sherwood","year":"2018","journal-title":"Am Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923008378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923008378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:48:06Z","timestamp":1757573286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923008378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":24,"alternative-id":["S0002914923008378"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.076","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742776220.793600855","asserted-by":"object"}]},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin Versus Warfarin after Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Follow-Up","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}